Clinical Trial Update: Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effectiveness of a booster dose strategy for Hepatitis A vaccine in HIV-infected individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Human Immunodeficiency Virus

Drugs mentioned

• HAV Vaccine

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatitis A, Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED